{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:43:01Z","timestamp":1793130181731,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00415-019-09557-w","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T02:06:44Z","timestamp":1570068404000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Risk factors for lymphopenia in patients with relapsing\u2013remitting multiple sclerosis treated with dimethyl fumarate"],"prefix":"10.1007","volume":"267","author":[{"given":"Fabian Sierra","family":"Morales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor J.","family":"Koralnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soleil","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0028-3031","authenticated-orcid":false,"given":"Jacob A.","family":"Sloane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,3]]},"reference":[{"issue":"12","key":"9557_CR1","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","volume":"367","author":"RJ Fox","year":"2012","unstructured":"Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT, CONFIRM Study Investigators (2012) Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med 367(12):1087\u20131097","journal-title":"N Engl J Med"},{"issue":"12","key":"9557_CR2","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","volume":"367","author":"R Gold","year":"2012","unstructured":"Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT, DEFINE Study Investigators (2012) Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 367(12):1098\u20131107","journal-title":"N Engl J Med"},{"key":"9557_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000017903","volume":"196","author":"S Hoxtermann","year":"1998","unstructured":"Hoxtermann S, Nuchel C, Altmeyer P (1998) Fumaric acid esters suppress peripheral CD4- and CD8-positive lymphocytes in psoriasis. Dermatology 196:223\u2013230","journal-title":"Dermatology"},{"key":"9557_CR4","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1212\/NXI.0000000000000076","volume":"2","author":"C Spencer","year":"2015","unstructured":"Spencer C, Crabtree-Hartman EC, Lehmann-Horn K, Cree BA, Zamvil S (2015) Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate. Neurol Neuroimmunol Neuroinflamm 2:e76","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"Pt 9","key":"9557_CR5","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1093\/brain\/awh215","volume":"127","author":"RA Du Pasquier","year":"2004","unstructured":"Du Pasquier RA, Kuroda MJ, Zheng Y, Jean-Jacques J, Letvin NL, Koralnik IJ (2004) A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 127(Pt 9):1970\u20131978","journal-title":"Brain"},{"issue":"15","key":"9557_CR6","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1056\/NEJMc1415408","volume":"372","author":"T Rosenkranz","year":"2015","unstructured":"Rosenkranz T, Novas M, Terborg C (2015) PML in a patient with lymphocytopenia treated with dimethyl fumarate. N Engl J Med 372(15):1476\u20131478","journal-title":"N Engl J Med"},{"issue":"4","key":"9557_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/ana.24471","volume":"78","author":"T Bartsch","year":"2015","unstructured":"Bartsch T, Rempe T, Wrede A, Leypoldt F, Br\u00fcck W, Adams O, Rohr A, Jansen O, W\u00fcthrich C, Deuschl G, Koralnik IJ (2015) Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate. Ann Neurol 78(4):501\u2013514","journal-title":"Ann Neurol"},{"issue":"4","key":"9557_CR8","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1212\/WNL.0000000000002900","volume":"87","author":"K Lehmann-Horn","year":"2016","unstructured":"Lehmann-Horn K, Penkert H, Grein P, Leppmeier U, Teuber-Hanselmann S, Hemmer B, Berthele A (2016) PML during dimethyl fumarate treatment of multiple sclerosis: how does lymphopenia matter? Neurology 87(4):440\u2013441","journal-title":"Neurology"},{"issue":"5","key":"9557_CR9","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1212\/NXI.0000000000000274","volume":"3","author":"M Baharnoori","year":"2016","unstructured":"Baharnoori M, Lyons J, Dastagir A, Koralnik I, Stankiewicz JM (2016) Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate. Neurol Neuroimmunol Neuroinflamm 3(5):e274","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"9557_CR10","first-page":"1","volume":"1","author":"E Longbrake","year":"2015","unstructured":"Longbrake E, Naismith RT, Parks BJ, Wu GF, Cross AH (2015) Dimethyl fumarate-associated lymphopenia: risk factors and clinical significance. Mult Scler J Exp Transl Clin. 1:1\u20138","journal-title":"Mult Scler J Exp Transl Clin."},{"issue":"9","key":"9557_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1177\/106002809502900906","volume":"29","author":"DA Silverman","year":"1995","unstructured":"Silverman DA, Chapron DJ (1995) Lymphopenic effect of carbamazepine in a patient with chronic lymphocytic leukemia. Ann Pharmacother 29(9):865\u2013867","journal-title":"Ann Pharmacother"},{"issue":"2","key":"9557_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2165\/00002018-199921020-00003","volume":"21","author":"P Gergely","year":"1999","unstructured":"Gergely P (1999) Drug-induced lymphopenia. Drug Saf 21(2):91\u2013100","journal-title":"Drug Saf"},{"issue":"5","key":"9557_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1006\/cyto.1996.0047","volume":"8","author":"CO Pintado","year":"1996","unstructured":"Pintado CO, Carracedo J, Rodr\u00edguez M, P\u00e9rez-Calder\u00f3n R, Ram\u00edrez R (1996) 1 alpha, 25-dihydroxyvitamin D3 (calcitriol) induces apoptosis in stimulated T cells through an IL-2 dependent mechanism. Cytokine 8(5):342\u2013345","journal-title":"Cytokine"},{"issue":"5","key":"9557_CR14","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/ibd.20354","volume":"14","author":"M Martinesi","year":"2008","unstructured":"Martinesi M, Treves C, d\u2019Albasio G, Bagnoli S, Bonanomi AG, Stio M (2008) Vitamin D derivatives induce apoptosis and downregulate ICAM-1 levels in peripheral blood mononuclear cells of inflammatory bowel disease patients. Inflamm Bowel Dis 14(5):597\u2013604","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"9557_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1210\/jc.2002-020978","volume":"88","author":"S Arunabh","year":"2003","unstructured":"Arunabh S, Pollack S, Yeh J, Aloia JF (2003) Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 88(1):157\u2013161","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9557_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.metabol.2008.10.017","volume":"58","author":"SJ Winters","year":"2009","unstructured":"Winters SJ, Chennubhatla R, Wang C, Miller JJ (2009) Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women. Metabolism 58(4):438\u2013442","journal-title":"Metabolism"},{"issue":"7","key":"9557_CR17","doi-asserted-by":"publisher","first-page":"e101906","DOI":"10.1371\/journal.pone.0101906","volume":"9","author":"J \u0160ilhav\u00fd","year":"2014","unstructured":"\u0160ilhav\u00fd J, Z\u00eddek V, Mlejnek P, Landa V, \u0160im\u00e1kov\u00e1 M, Strnad H, Oliyarnyk O, \u0160kop V, Kazdov\u00e1 L, Kurtz T, Pravenec M (2014) Fumaric acid esters can block pro-inflammatory actions of human CRP and ameliorate metabolic disturbances in transgenic spontaneously hypertensive rats. PLoS One 9(7):e101906","journal-title":"PLoS One"},{"key":"9557_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.pmedr.2016.08.009","volume":"4","author":"T Higuchi","year":"2016","unstructured":"Higuchi T, Omata F, Tsuchihashi K, Higashioka K, Koyamada R, Okada S (2016) Current cigarette smoking is a reversible cause of elevated white blood cell count: cross-sectional and longitudinal studies. Prev Med Rep 4:417\u2013422","journal-title":"Prev Med Rep"},{"issue":"23","key":"9557_CR19","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1001\/jama.296.23.2832","volume":"296","author":"KL Munger","year":"2006","unstructured":"Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296(23):2832\u20132838","journal-title":"JAMA"},{"issue":"6","key":"9557_CR20","first-page":"359","volume":"15","author":"JM Bargman","year":"1989","unstructured":"Bargman JM, Silverman ED, Klein MH (1989) Effect of 1,25-dihydroxyvitamin D3 in vivo on circulating T lymphocytes. Miner Electrolyte Metab 15(6):359\u2013364","journal-title":"Miner Electrolyte Metab"},{"issue":"4","key":"9557_CR21","doi-asserted-by":"publisher","first-page":"e94500","DOI":"10.1371\/journal.pone.0094500","volume":"9","author":"LL Ritterhouse","year":"2014","unstructured":"Ritterhouse LL, Lu R, Shah HB, Robertson JM, Fife DA, Maecker HT, Du H, Fathman CG, Chakravarty EF, Scofield RH, Kamen DL, Guthridge JM, James JA (2014) Vitamin d deficiency in a multiethnic healthy control cohort and altered immune response in vitamin D deficient European\u2013American healthy controls. PLoS One 9(4):e94500","journal-title":"PLoS One"},{"issue":"1\u20132","key":"9557_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jneuroim.2007.11.014","volume":"194","author":"J Smolders","year":"2008","unstructured":"Smolders J, Damoiseaux J, Menheere P, Hupperts R (2008) Vitamin D as an immune modulator in multiple sclerosis. J Neuroimmunol 194(1\u20132):7\u201317","journal-title":"J Neuroimmunol"},{"issue":"2","key":"9557_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0090-1229(91)90017-5","volume":"59","author":"F Mili","year":"1991","unstructured":"Mili F, Flanders WD, Boring JR, Annest JL, Destefano F (1991) The associations of race, cigarette smoking, and smoking cessation to measures of the immune system in middle-aged men. Clin Immunol Immunopathol 59(2):187\u2013200","journal-title":"Clin Immunol Immunopathol"},{"issue":"5","key":"9557_CR24","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.humimm.2007.01.007","volume":"68","author":"MJ Nowicki","year":"2007","unstructured":"Nowicki MJ, Karim R, Mack WJ, Minkoff H, Anastos K, Cohen M, Greenblatt RM, Young MA, Gange SJ, Levine AM (2007) Correlates of CD4+ and CD8+ lymphocyte counts in high-risk immunodeficiency virus (HIV)-seronegative women enrolled in the women\u2019s interagency HIV study (WIHS). Hum Immunol 68(5):342\u2013349","journal-title":"Hum Immunol"},{"key":"9557_CR25","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1212\/WNL.0000000000007262","volume":"92","author":"D Mehta","year":"2019","unstructured":"Mehta D, Miller C, Arnold D, Bame E, Bar-Or A, Gold R, Hanna J, Kappos L (2019) Effect of dimethyl fumarate on lymphocytes in RRMS Implications for clinical practice. Neurology 92:e1\u2013e15","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.1007\/s00415-019-09626-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T00:00:00Z","timestamp":1574467200000}}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09557-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09557-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09557-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T20:03:28Z","timestamp":1601582608000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09557-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,3]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["9557"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09557-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,3]]},"assertion":[{"value":"21 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2019","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Unfortunately, the given name and family name of first author was incorrectly tagged in the xml data, therefore it is abbreviated wrongly as \u201cMorales FS\u201d in Pubmed. The correct given name is Fabian and family name is Sierra Morales. Auhtor name should be abbreviated as Sierra Morales F.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"JS has served on scientific advisory boards for Biogen, Genentech, EMD Serono, Sanofi\/Genzyme, and Teva, served as a consultant for Biogen and Roche, and has grant funding from Biogen, Genzyme, Genentech, and National MS Society. Other author(s) declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study was approved by the Institutional Review Board at the Beth Israel Deaconess Medical Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard"}}]}}